Andy Whitney, Phd Email and Phone Number
Andy Whitney, Phd work email
- Valid
- Valid
- Valid
Andy Whitney, Phd personal email
I’m an experienced scientific leader with a passion for translating scientific knowledge into therapeutics to help people live better lives. With an emphasis on building strong internal pipelines for autoimmune/inflammatory disease, oncology, metabolic and rare diseases I have had the opportunity to take multiple drug discovery projects and companies through successful business milestones (INDs, acquisitions, IPOs, and approvals).
-
Chief Scientific OfficerEnsho Therapeutics Jul 2024 - Present
-
PrincipalChoucas Consulting Llc Jun 2023 - PresentPreclinical and translational advisory and consulting services for biopharmaceutical companies
-
Svp, Research And Translational ScienceApplied Molecular Transport May 2022 - Mar 2023South San Francisco, Ca, UsLed AMT’s research and translational efforts to develop novel oral and inhaled biologic therapeutics for autoimmune and inflammatory and metabolic diseases.• Built-out company capabilities in discovery research, preclinical development, pharmacodynamic biomarkers/translational sciences.• Championed portfolio development and new programs; project leader for oral IL-22 program through preclinical testing and through successful (CTA) regulatory filing -
Vp, Preclinical Development And Translational ScienceApplied Molecular Transport Dec 2019 - May 2022South San Francisco, Ca, Us
-
Vice President Biology In ResidenceBridgebio 2018 - Dec 2019Palo Alto, California, UsLed nonclinical biology efforts for multiple BridgeBio subsidiaries focused on developing medicines for patients with genetically driven diseases. -
Director, BiologyGilead Sciences 2012 - 2018Foster City, Ca, UsStrategic leader in Gilead’s inflammation and oncology research; evaluated new inflammation and oncology targets and enhanced research and innovations through internal team leadership and collaborations.Project lead/lead biologist on multiple small molecule drug discovery projects in inflammation & oncology; including novel target for Inflammatory Bowel Disease – taken from initial project proposal through early stage discovery, development candidate selection, and IND filing.Lead nonclinical biologist on multiple phase 3 programs (including momelotinib for oncology and filgotinib for inflammatory bowel disease); directed mechanism of action studies to support clinical development, including potential combination treatments.Site Leadership roles for Gilead Connecticut & Seattle; cross-functional management to ensure scientific and operational excellence and integration with Gilead corporate headquarters -
Director, Structural ChemistryGilead Sciences 2010 - 2012Foster City, Ca, Us
-
Senior Director/Project Leader, Inflammation And Autoimmune DiseaseCgi Pharmaceuticals, Inc. 2008 - 2010Branford, Ct, UsProject Leader on pivotal pre-clinical program targeting Spleen Tyrosine Kinase (Syk) for autoimmune and oncological diseases; central to $120M acquisition of CGI by Gilead Sciences. -
Senior Director, Biology And InformaticsCgi Pharmaceuticals, Inc. 2005 - 2008Branford, Ct, UsDepartment head for biology and bioinformatics groupsKey member of R&D Leadership Team that built CGI from technology-based start-up into a fully integrated drug discovery company developing small molecule kinase inhibitors for oncology and autoimmune/inflammatory disease.Core member on multiple target validation and drug discovery projects (e.g. Btk) in autoimmune/inflammatory and oncology indications, including collaborations with large biotech and pharmaceutical companies.
-
Director/Principal Scientist/Senior Scientist, Research InformaticsCgi Pharmaceuticals, Inc. 1999 - 2005Branford, Ct, UsInstrumental in development of CGI’s research strategy and application of technology-based scientific programs, including establishing and managing biology, bioinformatics, and cheminformatics capabilities.
-
Postdoctoral FellowUniversity Of Geneva 1995 - 1999Genève, ChMentor: Dr. Thomas Kreis -
Research AssociateHarvard Medical School 1985 - 1988Boston, Ma, UsLaboratory of Dr. Marian Neutra
Andy Whitney, Phd Skills
Andy Whitney, Phd Education Details
-
Yale School Of MedicineCell Biology -
Harvard UniversityA.B.
Frequently Asked Questions about Andy Whitney, Phd
What company does Andy Whitney, Phd work for?
Andy Whitney, Phd works for Ensho Therapeutics
What is Andy Whitney, Phd's role at the current company?
Andy Whitney, Phd's current role is Chief Scientific Officer at Ensho Therapeutics.
What is Andy Whitney, Phd's email address?
Andy Whitney, Phd's email address is wh****@****dmt.com
What schools did Andy Whitney, Phd attend?
Andy Whitney, Phd attended Yale School Of Medicine, Harvard University.
What skills is Andy Whitney, Phd known for?
Andy Whitney, Phd has skills like Drug Discovery, Oncology, Cell Biology, Biotechnology, Drug Development, Lifesciences, Pharmaceutical Industry, Signal Transduction, Drug Design, Pharmacology, Biochemistry, Immunology.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial